Avinger Inc. (NASDAQ:AVGR)’s share price reached a new 52-week low on Thursday . The stock traded as low as $4.22 and last traded at $4.46, with a volume of 147,851 shares. The stock had previously closed at $4.37.

Several equities analysts recently weighed in on AVGR shares. BTIG Research reissued a “buy” rating and set a $18.00 price objective on shares of Avinger in a research report on Friday, July 15th. Canaccord Genuity reissued a “buy” rating on shares of Avinger in a research report on Tuesday, July 12th. Finally, Zacks Investment Research raised Avinger from a “sell” rating to a “hold” rating in a research report on Tuesday, May 3rd. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Avinger has an average rating of “Buy” and a consensus target price of $18.75.

The stock’s market capitalization is $56.28 million. The company’s 50-day moving average is $8.86 and its 200-day moving average is $11.52.

Avinger (NASDAQ:AVGR) last released its quarterly earnings results on Monday, August 1st. The medical device company reported ($1.06) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($1.15) by $0.09. The firm earned $4.70 million during the quarter, compared to analyst estimates of $3.05 million. Equities analysts expect that Avinger Inc. will post ($4.34) earnings per share for the current year.

In other Avinger news, insider Himanshu Patel sold 10,000 shares of Avinger stock in a transaction dated Friday, May 6th. The stock was sold at an average price of $13.40, for a total value of $134,000.00. Following the sale, the insider now owns 87,220 shares of the company’s stock, valued at approximately $1,168,748. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Donald A. Lucas sold 9,309 shares of Avinger stock in a transaction dated Friday, May 6th. The shares were sold at an average price of $12.58, for a total value of $117,107.22. The disclosure for this sale can be found here.

An institutional investor recently raised its position in Avinger stock. Paradigm Capital Management Inc. NY increased its stake in shares of Avinger Inc. (NASDAQ:AVGR) by 41.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 367,056 shares of the medical device company’s stock after buying an additional 108,222 shares during the period. Paradigm Capital Management Inc. NY owned 2.91% of Avinger worth $8,336,000 as of its most recent filing with the SEC.

Avinger, Inc is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses to introduce products based on its lumivascular platform, which is an intravascular image-guided system.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.